Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome

Francesca Mori, Giulia Liccioli, Oliver Fuchs, Simona Barni, Mattia Giovannini, Lucrezia Sarti, Elio Novembre, Jean Christoph Caubet

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

In 2014, drug-induced enterocolitis syndrome (DIES) was described for the first time. It is still a poorly known disease with symptoms that typically resemble those of food protein–induced enterocolitis syndrome (FPIES). To date, six more cases of DIES have been described and new clinical diagnostic criteria have been proposed based on those in the international guidelines for FPIES. In this paper, the authors describe three more cases of DIES. In addition, similarities and differences with FPIES have been deeply analyzed. To date, several unanswered questions need to be addressed, but clinicians must be instructed how to identify DIES, in order to make an allergy workup and give definite therapeutic indications to patients, especially in children where DIES seems to be more frequent.

Original languageEnglish
Pages (from-to)1165-1172
Number of pages8
JournalPediatric Allergy and Immunology
Volume32
Issue number6
DOIs
StatePublished - Aug 2021
Externally publishedYes

Keywords

  • beta-lactams
  • children
  • drug hypersensitivity reactions
  • drug-induced enterocolitis syndrome
  • food protein–induced enterocolitis syndrome

Fingerprint

Dive into the research topics of 'Drug-induced enterocolitis syndrome: Similarities and differences compared with food protein-induced enterocolitis syndrome'. Together they form a unique fingerprint.

Cite this